We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

125 hedge funds and large institutions have $641M invested in Cardiovascular Systems, Inc. in 2013 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 49 increasing their positions, 26 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 10

226% more call options, than puts

Call options by funds: $3.89M | Put options by funds: $1.19M

133% more funds holding in top 10

Funds holding in top 10: 37 (+4)

132% more capital invested

Capital invested by funds: $276M → $641M (+$365M)

88% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 26

39% more funds holding

Funds holding: 90125 (+35)

Holders
125
Holders Change
+35
Holders Change %
+38.89%
% of All Funds
3.63%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.2%
New
45
Increased
49
Reduced
26
Closed
10
Calls
$3.89M
Puts
$1.19M
Net Calls
+$2.69M
Net Calls Change
+$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
CM
26
Castleark Management
Illinois
$6.45M +$5.47M +187,950 New
EI
27
EAM Investors
California
$5.83M +$26.7K +916 +0.5%
Millennium Management
28
Millennium Management
New York
$5.83M -$584K -20,072 -11%
SCA
29
SAC Capital Advisors
Connecticut
$5.83M +$4.94M +169,931 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$5.52M +$1.85M +63,614 +65%
O
31
OppenheimerFunds
New York
$5.16M +$4.38M +150,512 New
GPCM
32
Granite Point Capital Management
Massachusetts
$5.14M +$4.36M +150,000 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$4.86M +$344K +11,830 +9%
NAM
34
Nichols Asset Management
Massachusetts
$4.77M +$4.05M +139,025 New
OM
35
Opaleye Management
Massachusetts
$4.46M +$3.93M +135,000 New
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$4.22M +$1.85M +63,679 +107%
TCM
37
Timpani Capital Management
Wisconsin
$3.9M +$650K +22,331 +24%
RFC
38
Russell Frank Company
Washington
$3.79M +$1.39M +47,814 +72%
PCM
39
Perkins Capital Management
Minnesota
$3.74M -$3.6M -123,699 -53%
TCIM
40
TIAA CREF Investment Management
New York
$3.68M +$325K +11,169 +12%
Ameriprise
41
Ameriprise
Minnesota
$3.25M +$152K +5,232 +6%
Renaissance Technologies
42
Renaissance Technologies
New York
$3.24M +$2.75M +94,600 New
WA
43
WFG Advisors
Texas
$3.06M +$187K +6,425 +8%
TA
44
Teton Advisors
New York
$3.06M -$8.73K -300 -0.3%
MWNA
45
Marshall Wace North America
New York
$3.06M +$2.59M +89,107 New
Morgan Stanley
46
Morgan Stanley
New York
$2.58M +$269K +9,252 +14%
Invesco
47
Invesco
Georgia
$2.45M +$2.08M +71,433 New
BIM
48
BlackRock Investment Management
Delaware
$2.3M +$233K +7,998 +14%
AQR Capital Management
49
AQR Capital Management
Connecticut
$2.23M +$573K +19,680 +43%
CC
50
Curian Capital
Colorado
$2.21M +$28.8K +989 +2%

CSII Hedge Fund Activity: Q4 2013 in Review

125 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2013, worth a combined $641M — up 132% from $276M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new CSII positions and 10 closed out — a net gain of 35 holders — while 49 added to existing stakes and 26 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $33.5M. The largest seller was Fidelity Investments, cutting an estimated $14.6M.

  • 125 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2013, up from 90 in Q3 2013.
  • Funds reported $641M of Cardiovascular Systems, Inc. stock for Q4 2013, up 132% quarter-over-quarter.
  • 45 funds opened new Cardiovascular Systems, Inc. positions in Q4 2013 and 10 closed out, a net change of +35 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2013 was Waddell & Reed Financial, an estimated $33.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2013 was Fidelity Investments, an estimated $14.6M sold.

Based on aggregated 13F filings for Q4 2013.